|Bid||1.3400 x 1300|
|Ask||1.9500 x 1000|
|Day's Range||1.6700 - 1.7500|
|52 Week Range||0.9200 - 1.7500|
|Beta (3Y Monthly)||1.23|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Every investor in Genesis Healthcare, Inc. (NYSE:GEN) should be aware of the most powerful shareholder groups. Large...
Genesis Healthcare (GEN) delivered earnings and revenue surprises of 380.00% and -0.56%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Genesis Healthcare's (GEN) third-quarter results are likely to reflect weak revenues, partially offset by same store facility growth and lower expenses.
Genesis Healthcare (GEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: MDU Resources, AquaVenture, Tenet Healthcare, US Foods and Genesis Healthcare
Global economy is slowing down and IMF has turned pessimistic. This is the perfect time for investors to go defensive and invest in these five stocks.
The Zacks Analyst Blog Highlights: NRG Energy, Lannett Company, Genesis Healthcare, US Foods and Grocery Outlet